Experimental Flu Vaccine, Developed Using mRNA, Seen as Potential Game Changer

November 25, 2022

(STAT News) – An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine. (Read More)